This is the authors' abstract. We don't add key points for this paper.
The bleeding disorder immune thrombocytopenic purpura (ITP) is a model for immunological research and new biological treatment modalities of chronic inflammatory and autoimmune disorders. In ITP, immunologically susceptible subjects are recognisable by disturbances of the immune response on various levels. Children have mostly a transient or persistent form (below 12 months’ duration) and rarely have […]
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Paul Imbach (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: